Received Dec 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | LA |
I have DVT and PE; I have DVT and PE; This is a spontaneous report received from a Nurse. A 31-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DEEP VEIN THROMBOSIS (hospitalization), PULMONARY EMBOLISM (hospitalization) all with onset 2021, outcome "unknown" and all described as "I have DVT and PE". The patient was hospitalized for deep vein thrombosis, pulmonary embolism (hospitalization duration: 14 day(s)). Therapeutic measures were taken as a result of deep vein thrombosis, pulmonary embolism. Clinical course: the patient was hospitalized for 2 weeks and had to take a breath in it and had to take Eliquis and Aspirin. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Based on temporal association, there is reasonable possibility of causal association between the Reported events DEEP VEIN THROMBOSIS, PULMONARY EMBOLISM and the suspect drug The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None